Anika Therapeutics | ANIK - 営業経費





営業経費 変化する 日付
Abbott USD 9.31B 104M 2026-03
Agenus USD 19.81M 293.94M 2025-12
Agios Pharmaceuticals USD 130.77M 10.77M 2026-03
Anika Therapeutics USD 133.9M 103.93M 2026-03
Arrowhead Research USD 223.22M 10.86M 2025-12
Enanta Pharmaceuticals USD 126.59M 346.51M 2025-12
Halozyme Therapeutics USD 211.07M 74.73M 2025-12
Heron Therapeutics USD 40.55M 1.46M 2025-12
Insmed USD 513.55M 109.86M 2025-12
Integra LifeSciences USD 1.04B 673.49M 2026-03
Intrexon USD 61.56M 26.1M 2024-06
J&J USD 17.44B 1.53B 2026-03
Karyopharm Therapeutics USD 51.92M 9.9M 2025-12
Ligand Pharmaceuticals USD 8.29M 32.17M 2025-09
MacroGenics USD 53.32M 13.68M 2025-12
Merit Medical Systems USD 337.72M 2.02M 2026-03
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sanofi EUR 9.31B 1.2B 2026-03
Smith & Nephew USD 2.52B 84M 2025-12
Stryker USD 4.92B 284M 2026-03
Surmodics USD 29.51M 274.86M 2025-06
Veracyte USD 116M 7.24M 2025-12
Xencor USD 81.86M 13.35M 2025-12
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03